372 research outputs found
Phenomenology of the nMSSM from colliders to cosmology
Low energy supersymmetric models provide a solution to the hierarchy problem
and also have the necessary ingredients to solve two of the most outstanding
issues in cosmology: the origin of dark matter and baryonic matter. One of the
most attractive features of this framework is that the relevant physical
processes are related to interactions at the weak scale and therefore may be
tested in collider experiments in the near future. This is true for the Minimal
Supersymmetric Standard Model (MSSM) as well as for its extension with the
addition of one singlet chiral superfield, the so-called nMSSM. It has been
recently shown that within the nMSSM an elegant solution to both the problem of
baryogenesis and dark matter may be found, that relies mostly on the mixing of
the singlet sector with the Higgs sector of the theory. In this work we review
the nMSSM model constraints from cosmology and present the associated collider
phenomenology at the LHC and the ILC. We show that the ILC will efficiently
probe the neutralino, chargino and Higgs sectors, allowing to confront
cosmological observations with computations based on collider measurements. We
also investigate the prospects for a direct detection of dark matter and the
constraints imposed by the current bounds of the electron electric dipole
moment in this model.Comment: 44 pp, 10 figures; Fig.9 replaced; discussion on CP violation
extended and references added; few minor additions in text about details of
the cut
Indirect search for dark matter: prospects for GLAST
Possible indirect detection of neutralino, through its gamma-ray annihilation
product, by the forthcoming GLAST satellite from our galactic halo, M31, M87
and the dwarf galaxies Draco and Sagittarius is studied. Gamma-ray fluxes are
evaluated for the two representative energy thresholds, 0.1 GeV and 1.0 GeV, at
which the spatial resolution of GLAST varies considerably. Apart from dwarfs
which are described either by a modified Plummer profile or by a
tidally-truncated King profiles, fluxes are compared for halos with central
cusps and cores. It is demonstrated that substructures, irrespective of their
profiles, enhance the gamma-ray emission only marginally. The expected
gamma-ray intensity above 1 GeV at high galactic latitudes is consistent with
the residual emission derived from EGRET data if the density profile has a
central core and the neutralino mass is less than 50 GeV, whereas for a central
cusp only a substantial enhancement would explain the observations. From M31,
the flux can be detected above 0.1 GeV and 1.0 GeV by GLAST only if the
neutralino mass is below 300 GeV and if the density profile has a central cusp,
case in which a significant boost in the gamma-ray emission is produced by the
central black hole. For Sagittarius, the flux above 0.1 GeV is detectable by
GLAST provided the neutralino mass is below 50 GeV. From M87 and Draco the
fluxes are always below the sensitivity limit of GLAST.Comment: 14 Pages, 7 Figures, 3 Tables, version to appear on Physical Review
Model identification in reactor-based combustion closures using sparse symbolic regression
info:eu-repo/semantics/publishe
The recovery umbrella in the world of elite sport: Do not forget the coaching and performance staff
In the field of sports science, the recovery umbrella is a trending topic, and even more so in the world of elite sports. This is evidenced by the significant increase in scientific publications during the last 10 years as teams look to find a competitive edge. Recovery is recognized to be an integral component to assist athlete preparation in the restoration of physical and psychological function, and subsequently, performance in elite team sports athletes. However, the importance of recovery in team staff members (sports coaches and performance staff) in elite sports appears to be a forgotten element. Given the unrelenting intense nature of daily tasks and responsibilities of team staff members, the elite sports environment can predispose coaches to increased susceptibility to psycho-socio physiological fatigue burden, and negatively affect health, wellbeing, and performance. Therefore, the aim of this opinion was to (1) develop an educational recovery resource for team staff members, (2) identify organizational task-specific fatigue indicators and barriers to recovery and self-care in team staff members, and (3) present recovery implementation strategies to assist team staff members in meeting their organizational functions. It is essential that we do not forget the coaching and performance staff in the recovery process. © 2021 by the authors. Licensee MDPI, Basel, Switzerland
Thermodynamics of phantom energy in the presence of a Reissner-Nordstrom black hole
In this paper, we study the validity of the generalized second law (GSL) in
phantom dominated universe in the presence of a Reissner-Nordstr\"{o}m (RN)
black hole. Our study is independent of the origin of the phantom like behavior
of the considered universe. We also discuss the GSL in the neighborhood of
transition from quintessence to phantom regime. We show that for a constant
equation of state parameter, the GSL may be satisfied provided that the
temperature is proportional to de Sitter temperature. It is shown that in
models with (only) a transition from quintessence to phantom regime the
generalized second law does not hold in the transition epoch. Next we show that
if the phantom energy has a chemical potential, then the GSL will hold if the
mass of black hole is above from a critical value.Comment: 5 pages, Accepted for publication in Astrophysics & Space Scienc
Fungos associados a grãos de café (Coffea arabica L.) beneficiados no sudoeste da Bahia
Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism
From the identification of HIV as the agent causing AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research over the past twenty-six years have been formidable. Currently, there are twenty-five anti-HIV compounds which have been formally approved for clinical use in the treatment of AIDS. These compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs), nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), cell entry inhibitors or fusion inhibitors (FIs), co-receptor inhibitors (CRIs), and integrase inhibitors (INIs). Metabolism by the host organism is one of the most important determinants of the pharmacokinetic profile of a drug. Formation of active or toxic metabolites will also have an impact on the pharmacological and toxicological outcomes. Therefore, it is widely recognized that metabolism studies of a new chemical entity need to be addressed early in the drug discovery process. This paper describes an overview of the metabolism of currently available anti-HIV drugs.Da identificação do HIV como o agente causador da AIDS, ao desenvolvimento de fármacos antirretrovirais eficazes, os avanços científicos na pesquisa sobre o HIV nos últimos vinte e seis anos foram marcantes. Atualmente, existem vinte e cinco fármacos anti-HIV formalmente aprovados pelo FDA para utilização clínica no tratamento da AIDS. Estes compostos são divididos em seis classes: inibidores nucleosídeos de transcriptase reversa (INTR), inibidores nucleotídeos de transcriptase reversa (INtTR), inibidores não-nucleosídeos de transcriptase reversa (INNTR), inibidores de protease (IP), inibidores da entrada celular ou inibidores de fusão (IF), inibidores de co-receptores (ICR) e inibidores de integrase (INI). O metabolismo consiste em um dos maiores determinantes do perfil farmacocinético de um fármaco. A formação de metabólitos ativos ou tóxicos terá impacto nas respostas farmacológicas ou toxicológicas do fármaco. Portanto, é amplamente reconhecido que estudos do metabolismo de uma nova entidade química devem ser realizados durante as fases iniciais do processo de desenvolvimento de fármacos. Este artigo descreve uma abordagem do metabolismo dos fármacos anti-HIV atualmente disponíveis na terapêutica
Commentaries on Viewpoint: Using V̇o<sub>2max</sub> as a marker of training status in athletes - can we do better?
- …
